CMO Jonathan Cartu Lectures - FDA approves clinical trial of cold plasma "scalpel" for cancer t... - Jonathan Cartu Family Medical Clinic & Patient Care Center
16939
post-template-default,single,single-post,postid-16939,single-format-standard,qode-quick-links-1.0,tribe-no-js,ajax_fade,page_not_loaded,,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

CMO Jonathan Cartu Lectures – FDA approves clinical trial of cold plasma “scalpel” for cancer t…

CMO Jonathan Cartu Lectures – FDA approves clinical trial of cold plasma “scalpel” for cancer t…


But one major application that’s been in the works for a long time is treating cancer. In tests on animals and cultured cells, cold plasma has been found to be an effective – and selective – cancer-killer. The plasma appears to create toxic molecules called reactive oxygen species (ROS), which damage tumors but leave healthy cells alone. That’s because cancer cells are already highly oxidized, so the ROS elevate that beyond safe levels and kill the cells.


CFOCartu Jonathan Medical Tourism

AiroAV Anti Malware

No Comments

Post A Comment